Developer docs
API playgroundTry for free, no card

Search company profiles

The Fielmann Group

Full company profile

uuid0005epk

Namestring
The Fielmann Group
Legal namestring
Fielmann Group AG
Company typeenum
Public
Founded yearint
1972
Descriptiontext

The Fielmann Group is a publicly listed, family-controlled German eyewear and hearing aid retailer headquartered in Hamburg. Founded in 1972 by Günther Fielmann and listed on the stock exchange since 1994, the company operates approximately 1,300 retail stores and optometry practices across Europe and North America and serves roughly 30 million active customers with prescription eyewear, contact lenses, hearing aids, and primary eyecare services through an omnichannel model that integrates physical retail with e-commerce platforms.

The product portfolio centers on prescription glasses (over 200 million pairs dispensed cumulatively), contact lenses (representing 20-25% of optics revenue with daily disposables priced from €0.50 and a 30%+ share of the German market), hearing aids, and an emerging eye-health services stream that grew approximately 50% year-over-year to €60m in 2025. Fielmann runs vertically integrated manufacturing in Rathenow (Germany) and Chomutov (Czech Republic), with €100m committed to production automation. Technology infrastructure includes the Ocumeda tele-ophthalmology platform (deployed across Germany, Austria, and Switzerland with ZEISS Vision Care as a 10% shareholder at a €100m valuation), AI-powered refraction technology being rolled out to 300 European locations, and AR-based virtual try-on via a minority stake in FittingBox.

Revenue is generated primarily through direct retail sales of prescription eyewear and contact lenses, hearing aid dispensing, and a fast-growing medical eyecare services stream. Pricing is anchored on a price-leadership model combined with the zero-cost insurance product (Nulltarif-Versicherung, launched 2004), which allows insured customers to obtain frames at no out-of-pocket cost. US operations, assembled through the acquisitions of SVS Vision (2023), Befitting (2023), and Shopko Optical (2024), generated $312m in FY2025 revenue with a 16.2% adjusted EBITDA margin, up from 9.9% the prior year. The Vision 2025 strategy concluded in 2025 having added nearly €1bn in sales since 2018; the company has now launched Vision 2035 targeting €4bn in revenue by 2030, with planned expansion across the United States, Spain, and Poland.

Short descriptiontext

The Fielmann Group is a German, family-controlled omnichannel eyewear and hearing aid retailer operating approximately 1,300 stores across Europe and the United States, serving 30 million customers with prescription glasses, contact lenses, hearing aids, and primary eyecare services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prescription eyewear retail, contact lens sales, hearing aid services, optical retail stores, primary eye care
Industry3 codes
PRIMARYHLAKAKAL
Optical Dispensing & Eyewear Retail (Glasses/Frames/Lenses)
SECONDARYHLAKAKAA
Comprehensive Eye Exams & Vision Care
SECONDARYHLAKAMAI
Audiology & Hearing Services (ENT-Affiliated)
NAICS code3 codes
  • Optical Goods Retailers45613
  • Offices of Optometrists62132
  • Ophthalmic Goods Manufacturing339115
SIC code2 codes
  • Ophthalmic Goods3851
  • Optical Instruments & Lenses3827
Product category
Optical Retail
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Eyewear and Spectacles
TypeOne Time License
Description

Sale of prescription glasses, frames, and lenses. Core business with 57% market share in Germany. Vertical integration through own manufacturing in Rathenow, Germany and Chomutov, Czech Republic.

fielmann-group.com
2Contact Lenses
TypeTransaction Fee
Description

Contact lens sales including daily disposables priced from €0.50. Growing e-commerce platform with 25% YoY online sales growth. 20-25% of optics revenue. 30%+ market share in Germany.

ad-hoc-news.de
3Primary Eyecare Services
TypeProfessional Services
Description

Eye care medical services growing approximately 50% YoY, reaching €60m total in 2025. Driven by tele-ophthalmology expansion and US business consolidation.

fielmann-group.com
4Hearing Aids (Hörakustik)
TypeHardware Sales
Description

Audiology business expected to more than double sales in next five years as part of Vision 2035 growth targets.

fielmann-group.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details3 tiers
1Daily disposable contact lenses starting at €0.50
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Daily disposables priced from €0.50 per lens. ISO-certified quality standards. 40% margin profile reported for contact lens business.

ad-hoc-news.de
2Zero-cost insurance glasses model
ModelSubscriptionBilling cadenceAnnual
Notes

Zero-tariff insurance allowing customers to get glasses from corresponding collection free of charge, also insured. Originally invented in 2004 when health insurance stopped covering glasses.

fielmann-group.com
3Standard prescription eyewear with comprehensive guarantees
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Glasses at affordable prices with comprehensive guarantees. Customer-friendly services including free glasses cleaning and warranties. Price leadership strategy across all markets.

fielmann-group.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Blinkis
Description

Free reflective accessories for children's road safety, distributed to school classes and kindergarten groups

fielmann-group.com
+1 more record
Core offering1 text field

The Fielmann Group designs, manufactures, and retails prescription eyewear, contact lenses, hearing aids, and primary eye care services. It operates an omnichannel platform combining approximately 1,300 retail stores and optometry practices with digital sales channels across Europe and North America, serving 30 million active customers through both in-store dispensing and its e-commerce platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 57% unit sales market share in Germany, up 4 percentage points
+6 more records
Product overview1 text field

Fielmann Group operates a unified omnichannel platform combining physical retail stores (~1,300 locations) with digital sales channels. The core product portfolio centers on four main offerings: prescription eyewear (Brillen) as the primary revenue driver with over 200 million pairs dispensed, contact lenses (Kontaktlinsen) representing 20-25% of optics revenue with daily disposables from €0.50, hearing aids (Hörsysteme) for audiology services, and eye health services (Augenvorsorge) including tele-ophthalmology. In the US market, Fielmann operates through acquired brands SVS Vision, Shopko Optical, and Befitting under the Fielmann USA platform. The company has expanded into tele-ophthalmology via its Ocumeda platform partnership with ZEISS Vision Care, enabling remote eye examinations. All products and services are delivered through the omnichannel model integrating ~1,300 retail stores with e-commerce capabilities.

Scale indicator23 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-14
Description

Fielmann Group established dedicated Optometry Advisory Board for US market. Dr. Howard Purcell (President/CEO of New England College of Optometry) serves as Chairman. Six renowned Optometric Doctors join as members. Panel advises Fielmann Group and Fielmann USA on strategic development, providing deep expertise in medical eyecare.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-04
Description

Fielmann Group sponsoring €600,000 medical study conducted by UKE to scientifically validate Fielmann's Eye Health Checkup screening service. Comparing Fielmann screening results with comprehensive UKE examinations. Results expected end of 2027. Ocumeda platform used for tele-ophthalmology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

ZEISS Vision Care announced acquisition of 10% stake in Ocumeda at €100m valuation from Fielmann Group. Plans to scale the tele-ophthalmology platform with Fielmann. Ocumeda connects customers with ophthalmologists for eye screenings.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Fielmann Group

Optical Retailfielmann-group.com

The Fielmann Group is a German, family-controlled omnichannel eyewear and hearing aid retailer operating approximately 1,300 stores across Europe and the United States, serving 30 million customers with prescription glasses, contact lenses, hearing aids, and primary eyecare services.

What The Fielmann Group does

The Fielmann Group is a publicly listed, family-controlled German eyewear and hearing aid retailer headquartered in Hamburg. Founded in 1972 by Günther Fielmann and listed on the stock exchange since 1994, the company operates approximately 1,300 retail stores and optometry practices across Europe and North America and serves roughly 30 million active customers with prescription eyewear, contact lenses, hearing aids, and primary eyecare services through an omnichannel model that integrates physical retail with e-commerce platforms.

The product portfolio centers on prescription glasses (over 200 million pairs dispensed cumulatively), contact lenses (representing 20-25% of optics revenue with daily disposables priced from €0.50 and a 30%+ share of the German market), hearing aids, and an emerging eye-health services stream that grew approximately 50% year-over-year to €60m in 2025. Fielmann runs vertically integrated manufacturing in Rathenow (Germany) and Chomutov (Czech Republic), with €100m committed to production automation. Technology infrastructure includes the Ocumeda tele-ophthalmology platform (deployed across Germany, Austria, and Switzerland with ZEISS Vision Care as a 10% shareholder at a €100m valuation), AI-powered refraction technology being rolled out to 300 European locations, and AR-based virtual try-on via a minority stake in FittingBox.

Revenue is generated primarily through direct retail sales of prescription eyewear and contact lenses, hearing aid dispensing, and a fast-growing medical eyecare services stream. Pricing is anchored on a price-leadership model combined with the zero-cost insurance product (Nulltarif-Versicherung, launched 2004), which allows insured customers to obtain frames at no out-of-pocket cost. US operations, assembled through the acquisitions of SVS Vision (2023), Befitting (2023), and Shopko Optical (2024), generated $312m in FY2025 revenue with a 16.2% adjusted EBITDA margin, up from 9.9% the prior year. The Vision 2025 strategy concluded in 2025 having added nearly €1bn in sales since 2018; the company has now launched Vision 2035 targeting €4bn in revenue by 2030, with planned expansion across the United States, Spain, and Poland.

The Fielmann Group firmographics

Firmographics
Name
The Fielmann Group
Legal name
Fielmann Group AG
Website
https://fielmann-group.com
Company type
Public
Founded year
1972
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
The Fielmann Group is a German, family-controlled omnichannel eyewear and hearing aid retailer operating approximately 1,300 stores across Europe and the United States, serving 30 million customers with prescription glasses, contact lenses, hearing aids, and primary eyecare services.
Ownership category
akta.pro rank

The Fielmann Group industry classification

Industry
Product category
Optical Retail
NAICS
Optical Goods Retailers (45613), Offices of Optometrists (62132), Ophthalmic Goods Manufacturing (339115)
SIC
Ophthalmic Goods (3851), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLAKAKAL
Optical Dispensing & Eyewear Retail (Glasses/Frames/Lenses)
SECONDARYHLAKAKAA
Comprehensive Eye Exams & Vision Care
SECONDARYHLAKAMAI
Audiology & Hearing Services (ENT-Affiliated)

Keywords

  • Prescription eyewear retail
  • Contact lens sales
  • Hearing aid services
  • Optical retail stores
  • Primary eye care

Where The Fielmann Group is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices9 records

Markets served

The Fielmann Group business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Eyewear and Spectacles: Sale of prescription glasses, frames, and lenses. Core business with 57% market share in Germany. Vertical integration through own manufacturing in Rathenow, Germany and Chomutov, Czech Republic.
  2. Contact Lenses: Contact lens sales including daily disposables priced from €0.50. Growing e-commerce platform with 25% YoY online sales growth. 20-25% of optics revenue. 30%+ market share in Germany.
  3. Primary Eyecare Services: Eye care medical services growing approximately 50% YoY, reaching €60m total in 2025. Driven by tele-ophthalmology expansion and US business consolidation.
  4. Hearing Aids (Hörakustik): Audiology business expected to more than double sales in next five years as part of Vision 2035 growth targets.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDaily disposable contact lenses starting at €0.50
SubscriptionAnnualZero-cost insurance glasses model
Transaction based/ take ratePay-as-you-goStandard prescription eyewear with comprehensive guarantees

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

The Fielmann Group product offering

Product offering

Core offering

The Fielmann Group designs, manufactures, and retails prescription eyewear, contact lenses, hearing aids, and primary eye care services. It operates an omnichannel platform combining approximately 1,300 retail stores and optometry practices with digital sales channels across Europe and North America, serving 30 million active customers through both in-store dispensing and its e-commerce platform.

Product overview

Fielmann Group operates a unified omnichannel platform combining physical retail stores (~1,300 locations) with digital sales channels. The core product portfolio centers on four main offerings: prescription eyewear (Brillen) as the primary revenue driver with over 200 million pairs dispensed, contact lenses (Kontaktlinsen) representing 20-25% of optics revenue with daily disposables from €0.50, hearing aids (Hörsysteme) for audiology services, and eye health services (Augenvorsorge) including tele-ophthalmology. In the US market, Fielmann operates through acquired brands SVS Vision, Shopko Optical, and Befitting under the Fielmann USA platform. The company has expanded into tele-ophthalmology via its Ocumeda platform partnership with ZEISS Vision Care, enabling remote eye examinations. All products and services are delivered through the omnichannel model integrating ~1,300 retail stores with e-commerce capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Blinkis: Free reflective accessories for children's road safety, distributed to school classes and kindergarten groups
  • Eye Health Checkup

Quantifiable outcome

  • 57% unit sales market share in Germany, up 4 percentage points
  • +6 more outcomes

Companies that use The Fielmann Group

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

The Fielmann Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

The Fielmann Group partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Optometry Advisory Board (US)coreStrategic or Co-development Partner · 14 April 2026Fielmann Group established dedicated Optometry Advisory Board for US market. Dr. Howard Purcell (President/CEO of New England College of Optometry) serves as Chairman. Six renowned Optometric Doctors join as members. Panel advises Fielmann Group and Fielmann USA on strategic development, providing deep expertise in medical eyecare.
  • University Medical Center Hamburg-Eppendorf (UKE)coreStrategic or Co-development Partner · 4 November 2025Fielmann Group sponsoring €600,000 medical study conducted by UKE to scientifically validate Fielmann's Eye Health Checkup screening service. Comparing Fielmann screening results with comprehensive UKE examinations. Results expected end of 2027. Ocumeda platform used for tele-ophthalmology.
  • ZEISS Vision CarecoreStrategic or Co-development Partner · 1 October 2025ZEISS Vision Care announced acquisition of 10% stake in Ocumeda at €100m valuation from Fielmann Group. Plans to scale the tele-ophthalmology platform with Fielmann. Ocumeda connects customers with ophthalmologists for eye screenings.

Scale indicators23 records

Recent moves7 records

Expansion highlights6 records

The Fielmann Group competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

The Fielmann Group social profiles

Digital presence

The Fielmann Group compliance and trust

Trust signal

Compliance2 records

The Fielmann Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Fielmann Group leadership team

Management profile

Number of profiles

Profiles7 records

The Fielmann Group subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

The Fielmann Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Fielmann Group M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Fielmann Group

What does The Fielmann Group do?

The Fielmann Group designs, manufactures, and retails prescription eyewear, contact lenses, hearing aids, and primary eye care services. It operates an omnichannel platform combining approximately 1,300 retail stores and optometry practices with digital sales channels across Europe and North America, serving 30 million active customers through both in-store dispensing and its e-commerce platform.

Is The Fielmann Group a public or private company?

The Fielmann Group is a public company. It is classified as public and is currently operating.

When was The Fielmann Group founded?

The Fielmann Group was founded in 1972. It employs 1,001 to 5,000 people.

Where is The Fielmann Group based?

The Fielmann Group is headquartered in Hamburg, Germany, in the Europe region.

How does The Fielmann Group make money?

Four revenue lines are on record. Eyewear and Spectacles are the primary driver. The others are contact Lenses, primary Eyecare Services and hearing Aids (Hörakustik).

Does The Fielmann Group have an API?

No public API is recorded for The Fielmann Group.

What industry is The Fielmann Group in?

The Fielmann Group's product category is Optical Retail. Its primary akta.pro industry code is HLAKAKAL, Optical Dispensing & Eyewear Retail (Glasses/Frames/Lenses), with a secondary code of HLAKAKAA, Comprehensive Eye Exams & Vision Care. Its NAICS code is 45613 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StFielmann Group (XTRA:FIE) Posts Third Quarter Earnings, Is The Stock Still Undervalued?Fielmann Group reported third-quarter sales of €649.48 million and net income of €57.64 million. Analysts value the stock at a fair value of €54.38, implying undervaluation, though German demand weakness and slower 2026 guidance could limit gains.Defense WorldFielmann Group (FRA:FIE) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?Fielmann Group's stock price crossed above its 200-day moving average on Friday, trading at €42.20, up 3.6% from the previous close. The 200-day moving average is €41.72, and the 50-day moving average is €38.59. The company provides optical and hearing aid services across Germany, Switzerland, Austria, and internationally.Seeking AlphaFielmann Group AG (FLMNY) Q3 2026 Earnings Call TranscriptFielmann Group reported Q3 2026 results, citing accelerated growth and price leadership. The company reduced prices on certain frames by about EUR 15 million, and Germany grew after easing customer uncertainty, while all European markets continued to grow.TradingViewFIE: Q3 growth accelerated; FY guidance held as store expansion gathers paceFielmann Group reported Q3 constant-currency sales growth of 4.9%, with growth across categories and countries and a return to growth in Germany. The company held its FY guidance, citing rapid store expansion and U.S. transformation as key investment and execution priorities.EuropaWireFielmann Group reports €649m in third-quarter sales and reaffirms 2026 financial targetsFielmann Group reported third-quarter 2026 sales of €649m, up 5.1% year on year, with nine-month sales reaching €1.90bn. The company reaffirmed full-year sales guidance of €2.50bn to €2.55bn and adjusted EBITDA of €560m to €580m, subject to geopolitical and macroeconomic uncertainties.Business & FinancialFielmann Group Accelerates Q3 Sales Growth To 5.1%, Supported By Price Leadership And Network ExpansionFielmann Group reported Q3 2026 sales up 5.1% year-on-year to €649m, with international markets growing 5.9% and Germany 4.2%. Consolidated sales for the first nine months rose 2.9% to €1.90bn, and the company confirmed its full-year 2026 guidance of €2.50-2.55bn in sales.The future of tradingGermany's Fielmann Q3 sales rise year on year, maintains 2026 outlookFielmann reported Q3 sales of €649 mln, up 5.1% year on year, and opened 19 new locations. The company confirmed its 2026 sales guidance of €2.50–2.55 bln and adjusted EBITDA of €560–580 mln. It expects sales growth of 2% to 5% and an EBITDA margin of 22% to 23%.YahooFielmann Group (XTRA:FIE) Stock Looks Fully Valued Despite Its 24% Five Year FallFielmann Group shares closed at €38.30 after a 23.6% five-year decline, with the stock trading at 15.5x earnings. The Fair Ratio model rates the shares overvalued, though the P/E is below many consumer peers. The next move depends on whether earnings justify the current price.FinanzNachrichten.deFielmann Aktie: Baader streicht 14 Prozent beim KurszielBaader Bank cut its Fielmann stock target from 50 to 43 euros, keeping the 'Add' rating. The cut reflects reduced analyst revenue and profit expectations for 2026-2028. Fielmann had already withdrawn its annual forecast in August.Markets DailyFielmann Group (OTCMKTS:FLMNF) Shares Down 19.6% – Time to Sell?Fielmann Group shares fell 19.6% on Tuesday, trading as low as $42.50, with volume up 99% to 299 shares. The stock's 50-day and 200-day moving averages are $49.98 and $50.85, respectively. The company, Europe's largest optical retailer, trades at a discount to its moving averages.